Replies to post #21815 on RespireRx Pharmaceuticals Inc (RSPI)

[Aiming4]

Davidal - IF it is true that there are at least 2 companies that are very interested in licensing Ampakines for RD, then neither of them should feel comfortable sitting back and waiting for Cortex's cash to run low and Cortex should be using that leverage.

How secure are we in believing there are at least 2 such companies?

[gfp927z]

Davidal, Raising $6-8 mil in a PIPE at .40 cents would dilute by 15-20 mil shares, plus the warrants (probably 8-10 mil warrants). So the net effect would be a 50% dilution or more (23-30 mil new shares, boosting the total shares outstanding from ~47 mil to 70-77 mil shares). That's a heck of a price to pay for raising $6-8 mil. And it assumes a PIPE at .40 cents (could be lower).

[Market_Fest4]

Davidal,
I don't think another 6-8 months of cash will "strengthen COR bargaining position". I've heard this argument 4 or 5 times over the last ten years. You know what? COR never gets a deal and eventually they do another PIPE. It makes one wonder if this isn't just another long-running scam?

I mean here we are again. COR has strong initial proof in 2 indications. BPs are IP-poor. This is the perfect situation for COR, if legitimate, to get some BP interest, possibly a bidding war, and a great deal. And yet with the end of the year approaching, the sp is as low as ever.

Say what you want about current conditions etc. But, considering the supposed strength of pipeline, something doesn't smell right here.

Show me the GD money already!
MF4